Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-035203
Filing Date
2026-07-29
Accepted
2026-07-29 16:30:20
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 22057
  Complete submission text file 0001493152-26-035203.txt   23403
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Issuer) CIK: 0001849296 (see all company filings)

EIN.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O OKYO PHARMA LTD. 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Patil Rajkumar V. (Reporting) CIK: 0002124067 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41386 | Film No.: 261218097